Mounjaro 12.5 mg
Tirzepatide
Mounjaro 12.5mg helps manage weight and improve blood sugar in adults with type 2 diabetes by mimicking natural hormones that regulate appetite and insulin.
- Strengths 12.5 mg
- Form Injection
- Packaging Size 2.4ml x 4
- Packaging Type Box
- Manufacturer Eli Lilly
Description of Mounjaro 12.5 mg
Mounjaro 12.5mg is an advanced weight management and type 2 diabetes treatment designed to mimic the effects of incretin hormones. It helps regulate blood sugar and curb appetite, making it effective for patients needing both glycaemic control and weight loss support. Mounjaro works by enhancing insulin release while reducing glucose production and appetite. This injectable medication is administered once weekly under medical supervision. Mounjaro 12.5mg is suitable for adults with type 2 diabetes when diet and exercise alone aren’t enough. It is not recommended for use in type 1 diabetes or for weight loss without a prescription.
Ingredients of Mounjaro 12.5 mg
- Tirzepatide 12.5mg (GLP-1 and GIP receptor agonist)
Usage of Mounjaro 12.5 mg
- Inject subcutaneously once a week, as prescribed by your doctor.
- Rotate injection sites to avoid irritation.
- Follow a balanced diet and regular exercise plan alongside treatment.
Precautions for Mounjaro 12.5 mg
- Not for use in patients with type 1 diabetes.
- Avoid if you have a history of thyroid cancer or pancreatitis.
- Consult your doctor before use if pregnant, breastfeeding, or on other medications.
- Monitor blood sugar levels regularly.
More like this
Find related medicines from trusted suppliers. Explore similar products to ensure you get the right medication for your needs.
